{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:28:15Z","timestamp":1787538495587,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.coms.2021.12.001","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T19:08:05Z","timestamp":1651172885000},"page":"221-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Classification and Staging of Melanoma in the Head and Neck"],"prefix":"10.1016","volume":"34","author":[{"given":"Anthony M.","family":"Bunnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey M.","family":"Nedrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui P.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.coms.2021.12.001_bib1","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1001\/jamaoto.2019.2769","article-title":"Head and Neck Melanoma Incidence Trends in the Pediatric, Adolescent, and Young Adult Population of the United States and Canada, 1995-2014","volume":"145","author":"Bray","year":"2019","journal-title":"JAMA Otolaryngology\u2013Head Neck Surg"},{"issue":"33","key":"10.1016\/j.coms.2021.12.001_bib2","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.20.00198","article-title":"Systemic Therapy for Melanoma: ASCO Guideline","volume":"38","author":"Seth","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.coms.2021.12.001_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.32160","article-title":"Changes in population-level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century","author":"Pulte","year":"2019","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.coms.2021.12.001_bib4","first-page":"426","article-title":"The classification of melanoma.fusion in dogs","volume":"54","author":"McGovern","year":"1971","journal-title":"Minn Med"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib5","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.coms.2021.12.001_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.coms.2021.12.001_bib7","unstructured":"Massi D, Cree I, Elder DE, et\u00a0al. WHO classification of skin Tumours.; 2018."},{"issue":"6","key":"10.1016\/j.coms.2021.12.001_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.141.6.745","article-title":"Early detection of thick melanomas in the United States: beware of the nodular subtype","volume":"141","author":"Demierre","year":"2005","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.coms.2021.12.001_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1980.01640310043015","article-title":"Acral lentiginous melanoma","volume":"116","author":"Coleman","year":"1980","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.coms.2021.12.001_bib10","article-title":"Lentigo maligna and lentigo-maligna melanoma","volume":"55","author":"Clark","year":"1969","journal-title":"The Am J Pathol"},{"issue":"5","key":"10.1016\/j.coms.2021.12.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.01.012","article-title":"Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas","volume":"80","author":"Strazzulla","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.coms.2021.12.001_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0b013e3182868e82","article-title":"Rare presentations of primary melanoma and special populations: a systematic review","volume":"37","author":"Kottschade","year":"2014","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cll.2017.06.002","article-title":"Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing","volume":"37","author":"Lang","year":"2017","journal-title":"Clin Lab Med"},{"issue":"1","key":"10.1016\/j.coms.2021.12.001_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41598-017-00606-w","article-title":"Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel","volume":"7","author":"de Unamuno Bustos","year":"2017","journal-title":"Scientific Rep"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2020.03.053","article-title":"Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients","volume":"83","author":"Greenhaw","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.coms.2021.12.001_bib16","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jamadermatol.2020.1729","article-title":"Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit","volume":"156","author":"Grossman","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.coms.2021.12.001_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamadermatol.2020.1731","article-title":"Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis","volume":"156","author":"Marchetti","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.coms.2021.12.001_bib18","unstructured":"Galan A, Gastman B, Grossmann K, et\u00a0al. NCCN guidelines version 2.2021 melanoma: cutaneous continue NCCN guidelines Panel Disclosures.; 2021."},{"issue":"1","key":"10.1016\/j.coms.2021.12.001_bib19","article-title":"Cancer statistics, 2015. CA","volume":"65","author":"Siegel","year":"2015","journal-title":"A\u00a0Cancer J Clinicians"},{"issue":"36","key":"10.1016\/j.coms.2021.12.001_bib20","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final Version of 2009 AJCC Melanoma Staging and Classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.coms.2021.12.001_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.coms.2021.12.001_bib22","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1245\/s10434-016-5196-1","article-title":"Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management","volume":"23","author":"Ge","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.coms.2021.12.001_bib23","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA: A Cancer J Clinicians"},{"issue":"13","key":"10.1016\/j.coms.2021.12.001_bib24","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.38.8561","article-title":"Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia","volume":"30","author":"Green","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.coms.2021.12.001_bib25","article-title":"A\u00a0Multifactorial Analysis of Melanoma","volume":"188","author":"BALCH","year":"1978","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.coms.2021.12.001_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e3182306c72","article-title":"Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma","volume":"255","author":"Murali","year":"2012","journal-title":"Ann Surg"},{"issue":"35","key":"10.1016\/j.coms.2021.12.001_bib27","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.50.1114","article-title":"Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma","volume":"31","author":"Han","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"10.1016\/j.coms.2021.12.001_bib28","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-016-5137-z","article-title":"Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis","volume":"23","author":"Cordeiro","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib29","article-title":"Role of Sentinel Lymph Node Biopsy in Patients with Thin Melanoma","volume":"7","author":"Andtbacka","year":"2009","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"2","key":"10.1016\/j.coms.2021.12.001_bib30","first-page":"184","article-title":"The prognostic impact of the extent of ulceration in patients with clinical stage I\u2013 <scp>II<\/scp> melanoma: a multicentre study of the Italian Melanoma Intergroup ( <scp>IMI<\/scp> )","author":"Portelli","year":"2021","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.coms.2021.12.001_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19800615)45:12<3012::AID-CNCR2820451223>3.0.CO;2-O","article-title":"The prognostic significance of ulceration of cutaneous melanoma","volume":"45","author":"Balch","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.coms.2021.12.001_bib32","series-title":"AJCC Cancer staging manual","article-title":"Melanoma of the Skin","author":"Gershenwald","year":"2017"},{"issue":"S1","key":"10.1016\/j.coms.2021.12.001_bib33","article-title":"Melanoma pathology reporting and staging","volume":"33","author":"Scolyer","year":"2020","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.coms.2021.12.001_bib34","article-title":"Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma","volume":"255","author":"\u2019t Hout","year":"2012","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.coms.2021.12.001_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2016.08.066","article-title":"Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases","volume":"76","author":"Mandal\u00e0","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"16","key":"10.1016\/j.coms.2021.12.001_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2010.31.5812","article-title":"Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database","volume":"29","author":"Thompson","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.coms.2021.12.001_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.2358","article-title":"Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study","volume":"8","author":"Tejera-Vaquerizo","year":"2019","journal-title":"Cancer Med"},{"issue":"23","key":"10.1016\/j.coms.2021.12.001_bib38","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.40.3519","article-title":"Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline","volume":"30","author":"Wong","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/0194599811408554","article-title":"Sentinel Node Biopsy for Head and Neck Melanoma","volume":"145","author":"de Rosa","year":"2011","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"issue":"4","key":"10.1016\/j.coms.2021.12.001_bib40","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update","volume":"36","author":"Wong","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.coms.2021.12.001_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.14.0285","article-title":"Improved Survival After Lymphadenectomy for Nodal Metastasis From an Unknown Primary Melanoma","volume":"26","author":"Lee","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.coms.2021.12.001_bib42","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-014-3679-5","article-title":"Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease","volume":"21","author":"van der Ploeg","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.coms.2021.12.001_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-1-62","article-title":"F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET\/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review","volume":"1","author":"Schr\u00f6er-G\u00fcnther","year":"2012","journal-title":"Syst Rev"},{"issue":"8","key":"10.1016\/j.coms.2021.12.001_bib44","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2002.08.024","article-title":"Implications of Microscopic Satellites of the Primary and Extracapsular Lymph Node Spread in Patients With High-Risk Melanoma: Pathologic Corollary of Eastern Cooperative Oncology Group Trial E1690","volume":"20","author":"Rao","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.coms.2021.12.001_bib45","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-014-4100-0","article-title":"In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy","volume":"22","author":"Read","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.coms.2021.12.001_bib46","doi-asserted-by":"crossref","DOI":"10.5858\/133.10.1560","article-title":"Protocol for the Examination of Specimens From Patients With Melanoma of the Skin","volume":"133","author":"Frishberg","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"36","key":"10.1016\/j.coms.2021.12.001_bib47","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.coms.2021.12.001_bib48","article-title":"Prognostic factors in patients with metastatic malignant melanoma","volume":"72","author":"Sirott","year":"1993","journal-title":"A\u00a0Multivariate Analysis Cancer"},{"issue":"22","key":"10.1016\/j.coms.2021.12.001_bib49","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2000.18.22.3782","article-title":"Prognostic Factors in Metastatic Melanoma: A Pooled Analysis of Eastern Cooperative Oncology Group Trials","volume":"18","author":"Manola","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.coms.2021.12.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(02)00123-5","article-title":"Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments","volume":"38","author":"Keilholz","year":"2002","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.coms.2021.12.001_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/07357900802027073","article-title":"Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma","volume":"26","author":"Bedikian","year":"2008","journal-title":"Cancer Invest"},{"issue":"16","key":"10.1016\/j.coms.2021.12.001_bib52","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.coms.2021.12.001_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-014-1528-9","article-title":"Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma","author":"Kelderman","year":"2014","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/bjc.2015.467","article-title":"Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma","volume":"114","author":"Diem","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.coms.2021.12.001_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up \u2020","author":"Michielin","year":"2019","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.coms.2021.12.001_bib56","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1995.13.8.2104","article-title":"Role of computed tomography in the staging of patients with local-regional metastases of melanoma","volume":"13","author":"Buzaid","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.coms.2021.12.001_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/BF02305552","article-title":"Computed tomography in staging of patients with melanoma metastatic to the regional nodes","volume":"4","author":"Johnson","year":"1997","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/BF02306618","article-title":"Computed tomography in evaluation of patients with stage III melanoma","volume":"4","author":"Kuvshinoff","year":"1997","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.coms.2021.12.001_bib59","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-010-1272-0","article-title":"Clinical Value of Radiographic Staging in Patients Diagnosed With AJCC Stage III Melanoma","volume":"18","author":"Pandalai","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"10.1016\/j.coms.2021.12.001_bib60","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2006.05.6176","article-title":"Utility of Computed Tomography and Magnetic Resonance Imaging Staging Before Completion Lymphadenectomy in Patients With Sentinel Lymph Node\u2013Positive Melanoma","volume":"24","author":"Aloia","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.coms.2021.12.001_bib61","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-007-9399-3","article-title":"Yield and Predictors of Radiologic Studies for Identifying Distant Metastases in Melanoma Patients with a Positive Sentinel Lymph Node Biopsy","volume":"14","author":"Gold","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.coms.2021.12.001_bib62","doi-asserted-by":"crossref","DOI":"10.1001\/archsurg.139.8.831","article-title":"Routine Imaging of Asymptomatic Melanoma Patients With Metastasis to Sentinel Lymph Nodes Rarely Identifies Systemic Disease","volume":"139","author":"Miranda","year":"2004","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib63","doi-asserted-by":"crossref","DOI":"10.1097\/CMR.0b013e32815c10b0","article-title":"F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4mm","volume":"17","author":"Maubec","year":"2007","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.21189","article-title":"Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma","volume":"104","author":"Wagner","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.coms.2021.12.001_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/hed.23456","article-title":"No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma","author":"Bikhchandani","year":"2013","journal-title":"Head & Neck"},{"issue":"3","key":"10.1016\/j.coms.2021.12.001_bib66","doi-asserted-by":"crossref","DOI":"10.1001\/archsurg.141.3.284","article-title":"Futility of Fluorodeoxyglucose F 18 Positron Emission Tomography in Initial Evaluation of Patients With T2 to T4 Melanoma","volume":"141","author":"Clark","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.coms.2021.12.001_bib67","doi-asserted-by":"crossref","unstructured":"Gershenwald JE, Scolyer RA. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol. 25. 2017. doi:10.1245\/s10434-018-6513-7.","DOI":"10.1245\/s10434-018-6513-7"}],"container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104236992100114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104236992100114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:13:06Z","timestamp":1760904786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104236992100114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S104236992100114X"],"URL":"https:\/\/doi.org\/10.1016\/j.coms.2021.12.001","relation":{},"ISSN":["1042-3699"],"issn-type":[{"value":"1042-3699","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classification and Staging of Melanoma in the Head and Neck","name":"articletitle","label":"Article Title"},{"value":"Oral and Maxillofacial Surgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coms.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}